113 related articles for article (PubMed ID: 38440942)
1. Reliability of roadside oral fluid testing devices for ∆
Scherer JN; Vasconcelos M; Dalanhol CS; Govoni B; Dos Santos BP; Borges GR; de Gouveia GC; Viola PP; Carlson RLR; Martins AF; Costa JL; Huestis MA; Pechansky F
Drug Test Anal; 2024 Mar; ():. PubMed ID: 38440942
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
3. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ
Newmeyer MN; Swortwood MJ; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2017 Mar; 63(3):647-662. PubMed ID: 28188235
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
Musshoff F; Hokamp EG; Bott U; Madea B
Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
[TBL] [Abstract][Full Text] [Related]
5. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
7. Orally administered cannabidiol does not produce false-positive tests for Δ
McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
[TBL] [Abstract][Full Text] [Related]
8. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers.
Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F
Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788
[TBL] [Abstract][Full Text] [Related]
9. Implementation of the first comprehensive state oral fluid drug testing program for roadside screening and laboratory testing in DUID cases-A 5-year review.
Harper CE; Hudson JS; Tidwell K; Boswell R; Yong HL; Maxwell AJ
J Anal Toxicol; 2023 Nov; 47(8):694-702. PubMed ID: 37526020
[TBL] [Abstract][Full Text] [Related]
10. Roadside screening tests for cannabis use: A systematic review.
Wennberg E; Windle SB; Filion KB; Thombs BD; Gore G; Benedetti A; Grad R; Ells C; Eisenberg MJ
Heliyon; 2023 Apr; 9(4):e14630. PubMed ID: 37064483
[TBL] [Abstract][Full Text] [Related]
11. Detection of Δ
Suraev A; McCartney D; Kevin R; Gordon R; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2024 Feb; ():. PubMed ID: 38414100
[TBL] [Abstract][Full Text] [Related]
12. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
[TBL] [Abstract][Full Text] [Related]
13. On-site test for cannabinoids in oral fluid.
Desrosiers NA; Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Oct; 58(10):1418-25. PubMed ID: 22912396
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid.
Bosker WM; Theunissen EL; Conen S; Kuypers KP; Jeffery WK; Walls HC; Kauert GF; Toennes SW; Moeller MR; Ramaekers JG
Psychopharmacology (Berl); 2012 Oct; 223(4):439-46. PubMed ID: 22581391
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.
Desrosiers NA; Milman G; Mendu DR; Lee D; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jul; 406(17):4117-28. PubMed ID: 24828976
[TBL] [Abstract][Full Text] [Related]
16. The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safety.
Romano E; Moore C; Kelley-Baker T; Torres-Saavedra PA
Traffic Inj Prev; 2019; 20(7):667-672. PubMed ID: 31356118
[No Abstract] [Full Text] [Related]
17. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Canadian approved drug screening equipment cut-off levels for tetrahydrocannabinol (THC).
Copley H; Filbert A; Williams K
J Anal Toxicol; 2024 Mar; 48(3):165-170. PubMed ID: 38343275
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of RapidSTAT®, DrugWipe® 6S, DrugScreen® 5TK and DrugScreen® 7TR for on-site drug testing in German police roadside traffic patrol.
Liut J; Bott U; Madea B; Krämer M; Maas A
Drug Test Anal; 2022 Aug; 14(8):1407-1416. PubMed ID: 35343088
[TBL] [Abstract][Full Text] [Related]
20. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
